M&A Deal Summary |
|
|---|---|
| Date | 2022-10-03 |
| Target | IZI Medical |
| Sector | Medical Products |
| Buyer(s) | Halma |
| Sellers(s) | Shore Capital Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 138M GBP |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1894 |
| Sector | Safety/Security |
| Employees | 7,000 |
| Revenue | 1.5B GBP (2022) |
Halma is a UK-based group of technology companies that makes products for hazard detection and life protection. Halma was founded in 1894 and is based in Amersham.
| DEAL STATS | # |
|---|---|
| Overall | 54 of 54 |
| Sector (Medical Products) | 10 of 10 |
| Type (Add-on Acquisition) | 49 of 49 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 19 of 19 |
| Year (2022) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-08-09 |
Texecom
Haslingden, United Kingdom Texecom is a manufacturer of security sensor and alarm products including motion detectors, control panels and signalling equipment, perimeter protection devices, external sounders and fire detectors. Texecom was founded in 1986 and is based in Haslingden, United Kingdom. |
Sell | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 2009 |
| PE ASSETS | 350M USD |
| Size | Middle-Market |
| Type | Sector Focused |
Shore Capital Partners is a private equity group focused on opportunities in healthcare, food/beverages, and business services. Specific healthcare areas of interest include infusion therapy, laboratory services, laboratory products/distribution, outpatient rehab therapy, and behavioral health. Shore looks to invest in proven businesses with stable cash-flows and 'significant' growth potential. Prospective companies typically have $5 to $50 million in sales and $1 to $7 million of EBITDA. Shore Capital was formed in 2009 and is based in Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 10 |
| Sector (Medical Products) | 2 of 4 |
| Type (Add-on Acquisition) | 4 of 5 |
| State (Maryland) | 1 of 1 |
| Country (United States) | 8 of 10 |
| Year (2022) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-09-30 |
EyeSouth Partners
Atlanta, Georgia, United States EyeSouth Partners is an eye care physician services organization committed to partnering with leading physicians to build a premier network of eye care services in Georgia and the Southeast. EyeSouth’s partner practices’ clinical mission is to provide high-quality medical and surgical specialty eye care. The organization supports its affiliated practices and physician partners with capital, administrative resources, operating expertise, and strategic guidance with an absolute focus on clinical quality and a patient-first culture. EyeSouth Partners was formed in 2017 and is based in Atlanta, Georgia. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-02-07 |
Argentum
Geneva, Illinois, United States Argentum is a manufacturer and sells innovative wound care products across a wide number of clinical applications, including the Silverlon® (“Silverlon”) brand, its rapidly-growing, proprietary range of silver-based antimicrobial products. The core platform technology in Silverlon is a uniquely designed silver-plated nylon matrix that provides the powerful antimicrobial properties of silver ions in the dressing without staining the skin and without increasing bioburden. Silverlon dressings are used today by surgeons and other healthcare professionals around the world on surgical wounds, burns, chronic wounds, IV catheter-related wounds, and for negative pressure wound therapy. Argentum was founded in 2001 and is based in Geneva, Illinois. |
Sell | - |
